Published in Neurosci Lett on March 30, 1992
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol (1996) 1.12
Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci U S A (1994) 1.09
The pathogenesis of Alzheimer's disease: a reevaluation of the "amyloid cascade hypothesis". Int J Alzheimers Dis (2011) 0.97
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models. Clinics (Sao Paulo) (2011) 0.96
Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD. Arch Med Res (2012) 0.89
Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatry (1998) 0.86
Differences between Early and Late-Onset Alzheimer's Disease in Neuropsychological Tests. Front Neurol (2012) 0.86
Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease. Am J Pathol (1996) 0.84
Alzheimer's disease. Postgrad Med J (1992) 0.80
Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (1991) 16.77
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature (1982) 4.93
All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody. Cell (1981) 4.28
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology (2006) 4.06
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Corticobasal degeneration. Brain (1989) 3.20
Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett (1992) 2.85
beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature (1996) 2.82
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature (1990) 2.80
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord (1999) 2.30
APOE is linked to Alzheimer's disease in a large pedigree. Am J Med Genet (1997) 2.01
Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies. Brain Res (1984) 1.98
Monoclonal antibodies to mammalian neurofilaments. Biosci Rep (1981) 1.96
Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol (2000) 1.89
Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science (1999) 1.88
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol (1994) 1.80
Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett (1988) 1.77
Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain (1991) 1.74
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology (2009) 1.70
New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J Neurochem (1998) 1.69
Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain (1992) 1.66
A monoclonal antibody against neurofilament protein specifically labels a subpopulation of rat sensory neurones. J Comp Neurol (1984) 1.63
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Brain diseases. Ubiquitous variations in nerves. Nature (1989) 1.53
A new variant of prion disease. Lancet (1996) 1.48
Human homologues of the bacterial heat-shock protein DnaJ are preferentially expressed in neurons. Biochem J (1992) 1.47
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology (1996) 1.45
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol (2003) 1.44
Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem J (1991) 1.42
Acquired Brown's syndrome: an unusual cause. Br J Ophthalmol (1985) 1.40
A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet (1992) 1.40
A genetic defect causing Alzheimer's disease. Br J Hosp Med (1991) 1.39
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett (1999) 1.36
Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience (1996) 1.33
Glutamate slows axonal transport of neurofilaments in transfected neurons. J Cell Biol (2000) 1.33
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases. N Engl J Med (1985) 1.32
In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta. J Neurochem (1996) 1.31
Regulation of 70-kDa heat-shock-protein ATPase activity and substrate binding by human DnaJ-like proteins, HSJ1a and HSJ1b. Eur J Biochem (1994) 1.29
Intermediate filaments: a family of homologous structures. J Muscle Res Cell Motil (1981) 1.27
Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes. J Neurol Neurosurg Psychiatry (1986) 1.27
Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42. Neurosci Lett (2001) 1.23
Nitrocellulose-bound antigen repeatedly used for the affinity purification of specific polyclonal antibodies for screening DNA expression libraries. J Immunol Methods (1988) 1.23
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol (2001) 1.20
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol (2012) 1.19
Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem (1993) 1.18
Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol (1988) 1.17
The polypeptides of isolated brain 10nm filaments and their association with polymerized tubulin. Biochem J (1979) 1.16
Pick's disease: an immunocytochemical study of neuronal changes. Monoclonal antibodies show that Pick bodies share antigenic determinants with neurofibrillary tangles and neurofilaments. Acta Neuropathol (1983) 1.16
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Neurosci (2000) 1.14
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci (1999) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. Brain Res (1980) 1.12
New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (1989) 1.12
Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J Neurochem (1997) 1.11
Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study. Brain (1989) 1.10
Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis. J Neuroimmunol (1999) 1.10
Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci (2000) 1.10
Pick's disease is associated with mutations in the tau gene. Ann Neurol (2000) 1.10
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr (1999) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins. Curr Opin Neurol (2000) 1.08
Characteristics of the in vitro vasoactivity of beta-amyloid peptides. Exp Neurol (1998) 1.07
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging? Neurology (2000) 1.06
A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry (2002) 1.06
Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet (1999) 1.06
Neurofibrillary tangles in dementia pugilistica are ubiquitinated. J Neurol Neurosurg Psychiatry (1991) 1.05
Quantitative analysis of tau isoform transcripts in sporadic tauopathies. Brain Res Mol Brain Res (2005) 1.04
CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem (2000) 1.04
A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Biochem J (1991) 1.04
Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuroreport (1996) 1.02
Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad Sci (2002) 1.02
Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res (1998) 1.02
Direct autoradiographic visualisation in SDS-gels of lectin-binding components of the human erythrocyte membrane. FEBS Lett (1975) 1.02
Induction of neuronal death by alpha-synuclein. Eur J Neurosci (2000) 1.02
Specific neuronal localization by immunofluorescence of 10 nm filament polypeptides. J Neurocytol (1980) 1.02
The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS Lett (2002) 1.01
Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium. Lancet (1996) 1.01
Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Neurosci Lett (1998) 1.01
Confirmation of association between D10S583 and Alzheimer's disease in a case--control sample. Neurosci Lett (2002) 1.01
Resolving MRI abnormalities with progression of subacute sclerosing panencephalitis. Neuroradiology (1991) 1.01
Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol (1992) 1.01
Neurofilaments from mammalian central and peripheral nerve share certain polypeptides. FEBS Lett (1978) 1.00
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Immunohistological study of granulovacuolar degeneration using monoclonal antibodies to neurofilaments. J Neurol Neurosurg Psychiatry (1985) 0.99
Isolation of a cDNA for the rat heavy neurofilament polypeptide (NF-H). FEBS Lett (1986) 0.99